Menu
Back to Journals » OncoTargets and Therapy » Volume 12
Original Research
BRMS1 downregulation is a poor prognostic biomarker in anaplastic thyroid carcinoma patients
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,465 | Dovepress* | 4,182+ | 653 | 4,835 | |
| PubMed Central* | 283 | 115 | 398 | ||
| Totals | 4,465 | 768 | 5,233 | ||
| *Since 28 August 2019 | |||||
View citations on PubMed Central and Google Scholar